SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
Cc大熊
Lv1
30 积分
2023-09-24 加入
最近求助
最近应助
互助留言
A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance
21天前
已完结
Lymphotoxin-β promotes breast cancer bone metastasis colonization and osteolytic outgrowth
23天前
已完结
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer
2个月前
已完结
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer
2个月前
已完结
DevelopmentofSelectivePhosphatidylinositol5‑Phosphate 4‑KinaseγInhibitorswithaNon-ATP-competitive,AllostericBinding Mode
2个月前
已完结
Celastrol Targets Cullin-Associated and Neddylation-Dissociated 1 to Prevent Fibroblast−Myofibroblast Transformation against Pulmonary Fibrosis
2个月前
已完结
Development of Selective Phosphatidylinositol 5‑Phosphate 4‑Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode
2个月前
已完结
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer
3个月前
已完结
Targeting GDP-Dissociation Inhibitor Beta (GDI2) with a Benzo[a]quinolizidine Library to Induce Paraptosis for Cancer Therapy
3个月前
已完结
Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader
3个月前
已完结
Discovery of afimetoran, a small molecule dual antagonist of the toll-like receptors 7 and 8 (TLR7/8) advanced to clinical evaluation in patients with lupus
6个月前
已采纳
Flow field study of radiofrequency ablation of renal sympathetic nerve: Numerical simulation and PIV experiments
6个月前
已采纳
A review on biogenic synthesized zinc oxide nanoparticles: synthesis, characterization, and its applications
6个月前
已采纳
感谢
4个月前
感谢
5个月前
需要这篇文献的补充文件
5个月前
我需要这篇文献的补充文件
5个月前
已下载【积分已退回】
5个月前
速度真快
6个月前
点赞,速度真快
8个月前
感谢
8个月前
感谢
8个月前
速度真快,感谢,帮大忙了
10个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论